Table 5.
Females | Males | |||||
---|---|---|---|---|---|---|
Percent hip fracture cohort (N = 22,418) | Percent non-hip fracture cohort (N = 22,418) | Percent attributable | Percent hip fracture cohort (N = 7,611) | Percent non-hip fracture cohort (N = 7,611) | Percent attributable | |
Resource utilization | ||||||
Acute hospitalizations | 19.3 | 16.9 | 2.4* | 20.7 | 19.5 | 1.2 |
Same day surgeries | 8.6 | 11.5 | −2.9* | 11.2 | 17.2 | −6.0* |
Emergency visits | 32.1 | 36.6 | −4.5 | 30.6 | 33.8 | −3.2* |
Complex continuing care | 1.5 | 1.0 | 0.5* | 2.1 | 1.1 | 0.6* |
Rehabilitation | 1.8 | 1.1 | 0.7* | 1.5 | 0.9 | 0* |
Long-term care | 32.1 | 22.2 | 9.9* | 22.2 | 16.9 | 5.3* |
Community at index | 23.8 | 7.3 | 16.5* | 17.0 | 5.3 | 11.7* |
Home care | 29.1 | 23.6 | 5.5* | 24.5 | 19.5 | 5.0* |
Physician services | 76.5 | 85.0 | −8.5* | 65.2 | 83.7 | −18.5* |
DXA test | 6.6 | 8.8 | −2.2* | 3.3 | 1.9 | 1.4* |
Prescriptions | 75.6 | 84.0 | −8.4* | 63 | 81.6 | −18.6* |
Osteoporosis treatment | 37.0 | 26.1 | 10.9* | 16.6 | 6.2 | 10.4* |
Opioids | 27.4 | 24.7 | 2.7* | 22.7 | 21.7 | 1.0 |
NSAIDs | 13.8 | 19.5 | −5.7* | 11.7 | 18.7 | −7.0* |
Health outcomes | ||||||
Second hip fracture | 1.7 | 0 | 1.7 | 1.4 | 0 | 1.4* |
Death (overall) | 9.1 | 8.3 | 0.8* | 11.3 | 9.4 | 1.9* |
Age group | ||||||
66–69 | 4.8 | 1.7 | 3.1* | 7.8 | 1.7 | 6.1* |
70–74 | 5.6 | 2.7 | 2.9* | 8.4 | 3.9 | 4.5* |
75–79 | 7.7 | 4.9 | 2.8* | 10.2 | 6.7 | 3.5* |
80–84 | 8.2 | 6.4 | 1.8* | 11.7 | 10.2 | 1.5 |
85–89 | 10.2 | 9.8 | 0.4* | 12.6 | 12.8 | −0.2 |
90+ | 12.5 | 14.9 | −2.4* | 14.4 | 15.7 | −1.3 |
LTC at index | 12.4 | 17.2 | −4.8* | 14.2 | 19.7 | −5.5* |
Community at index | 8.2 | 5.8 | 2.4* | 10.7 | 7.1 | 3.6* |
Attributable percentage of hip fracture patients − percentage of non-hip fracture patients, LTC long-term care, NSAID nonsteroidal anti-inflammatory drug
* p < 0.05 (significant at this level)